Alvotech (ALVO) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Alvotech (ALVO) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $1.14B, listed on NASDAQ, employing roughly 1,460 people, carrying a beta of 0.19 to the broader market. Alvotech, along with its various subsidiaries, is dedicated to the global development and manufacturing of biosimilar pharmaceuticals. Led by Lisa Graver, public since 2022-06-16.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for ALVO as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →